Stellantis to Announce Full Year 2025 Results on February 26 Stellantis to Announce Full Year 2025 Results on February 26 AMSTERDAM, February 16, 2026 - announced today that its Full Year 2025 Results will be released on Thursday, February 26, 2026. A live audio webcast and conference call for Full Year 2025 Results will take place on Thursday, February 26, 2026, at 2:00 p.m. CET / 8:00 a.m. EST. The related press release and presentation materials are expected to be posted under the section of the Stellantis corporate website at approximately 8:00 a.m. CET / 2:00 a.m. EST on Thursda...
Company comments AB InBev: Little to disappoint Adyen: 2H25 results – mixed results, soft guidance CVC Capital Partners: Executing well dsm-firmenich: Messy results Fagron: Beat on all lines, confident FY26 outlook to drive c.5% consensus EBITDA upgrade Flow Traders: EMEA saves the day KBC: Good results, opening up “jaws” further to 2028 Kinepolis: Canadian peer Cineplex 4Q25 results below consensus, January 2026 box office revenue up MICC: FX headwind leads to a 50bp margin miss in FY25 Montea:...
4Q organic top line and EBITDA growth was slightly better than consensus. ABI FY26 guidance of 4-8% organic EBITDA growth is in line with the mid term guidance and our & consensus estimates at c. +5%. Total FY25 dividend is upped from € 1 to € 1.15, including an earlier interim dividend of € 0.15. We still see AB InBev as the undisputed leader in the beer market, with leading market shares in many markets, ongoing digitization and premiumization trends allowing to generate healthy free cash flow...
ING to redeem two series of SEC registered Senior Notes and announces the intention to call Tier 2 notes on the reset date ING to redeem two series of SEC registered Senior Notes and announces the intention to call Tier 2 notes on the reset date ING announced today it will redeem two series of outstanding SEC registered securities: the USD 400 million Callable Floating Rate Senior Notes (CUSIP 456837 AX1 / ISIN US456837AX12) and the USD 1,100 million 1.726% Callable Fixed-to-Floating Rate Senior Notes (CUSIP 456837 AV5/ ISIN US456837AV55) (together the “Callable Senior Notes”) on their con...
Medidata Delivers a Decade of AI Leadership to 500+ Clinical Studies and Growing Powered by Medidata’s AI technologies, complex clinical data is transformed, delivering significantly faster study build and shorter trial timelines NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, continues to accelerate clinical trial success for biopharmaceutical and medtech customers through enhanced AI-powered capabilities. Its AI technology has been scaled across the , benefiting over 500 clinical st...
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €1.1 billion share buyback programme announced on 30 October 2025, in total 1,556,401 shares were repurchased during the week of 2 February up to and including 6 February 2026. The shares were repurchased at an average price of €25.42 for a total amount of €39,556,159.66. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the updates on the on our website In line with the purpose of the programme to reduce ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.